(19)
(11)
EP 1 409 524 A2
(12)
(88)
Date of publication A3:
16.08.2001
(43)
Date of publication:
21.04.2004
Bulletin 2004/17
(21)
Application number:
00960836.5
(22)
Date of filing:
18.09.2000
(51)
International Patent Classification (IPC)
7
:
C07K
14/025
,
C12N
15/37
,
A61K
39/12
,
A61K
38/16
,
A61P
31/20
,
A61P
17/00
,
A61P
35/00
,
G06F
13/00
,
G06F
9/00
(86)
International application number:
PCT/GB2000/003568
(87)
International publication number:
WO 2001/021645
(
29.03.2001
Gazette 2001/13)
(84)
Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT
Designated Extension States:
AL LT LV MK RO SI
(30)
Priority:
17.09.1999
GB 9921938
(71)
Applicant:
Pro-Cure Therapeutics Limited
York YO10 5DG (GB)
(72)
Inventors:
ANTSON, Alfred
York YO10 5DD (GB)
MAITLAND, Norman
University of YorkYork YO10 5DD (GB)
(74)
Representative:
Gilholm, Stephen Philip
Harrison Goddard Foote31 St. Saviourgate
York Y01 8NQ
York Y01 8NQ (GB)
(54)
TARGET FOR ANTIVIRAL THERAPY